Owl Creek Asset Management’s Churchill Capital Corp III Warrants, each exercisable for one share of Class A common stock at an ex CCXX.WS Stock Holding History

Owl Creek Asset Management’s Portfolio CCXX.WS Stock Details CCXX.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-83,333	Closed	-$167K	–	188
2020 Q3	$167K	Hold	83,333	–	–	0.01%	97
2020 Q2	$250K	Buy	+83,333	New	+$153K	0.02%	74

Other funds holding CCXX.WS

RCM

Ratan Capital Management Miami Beach, Florida $269M AUM 45.74% 1-Year Est. Return

Owl Creek Asset Management's CCXX.WS Position: Q4 2020 in Review

Owl Creek Asset Management sold out of Churchill Capital Corp III Warrants, each exercisable for one share of Class A common stock at an ex (CCXX.WS) in Q4 2020, closing a stake of 83,333 shares — an estimated $167K sold.

Owl Creek Asset Management first reported a position in CCXX.WS in Q2 2020 and held it in 2 quarters. The position peaked at $250K in Q2 2020. 1 fund tracked by Wall St. Rank holds CCXX.WS as of Q4 2020.

Owl Creek Asset Management reported no remaining Churchill Capital Corp III Warrants, each exercisable for one share of Class A common stock at an ex position as of Q4 2020 after selling out during the quarter.
Owl Creek Asset Management sold 83,333 Churchill Capital Corp III Warrants, each exercisable for one share of Class A common stock at an ex shares in Q4 2020, an estimated $167K.
Owl Creek Asset Management first reported a position in Churchill Capital Corp III Warrants, each exercisable for one share of Class A common stock at an ex in Q2 2020 and held it in 2 quarters.
Owl Creek Asset Management's Churchill Capital Corp III Warrants, each exercisable for one share of Class A common stock at an ex position peaked at $250K in Q2 2020.
1 fund tracked by Wall St. Rank held Churchill Capital Corp III Warrants, each exercisable for one share of Class A common stock at an ex as of Q4 2020.

Based on Owl Creek Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.